KRAS and pancreatic neoplasm: Importantly, inhibition of GOT1 can promote pancreatic cancer cell ferroptosis [195]; it was found that KRAS-mutated cancer cells rely heavily on GOT1 for long-term proliferation, and GOT1 inhibition sensitizes the malignant cells to glucose deprivation [196].